Early phase I study of non-viral CD19/CD22/BCMA tri-targeting JL-Lightning-CAR-T in relapsed/refractory B-cell non-Hodgkin's lymphoma.
Jinxing Lou(Shanghai University), Qijun Qian(Shanghai University), Qingping Zou(Shanghai Cell Therapy Research Institute), Lijie Rong(Shanghai Cell Therapy Research Institute), Hongfan Zhu(Shanghai Cancer Institute), Bin Wang(Hebei Medical University), Zhi‐Feng Miao(Kaohsiung Medical University), Shuya Wang(Central South University), Wenfeng Xu(Vyne Therapeutics (United States)), Zhicai Lin(Shanghai Cell Therapy Research Institute), Yan Sun(Shanghai University), Mengxin Xia(Shanghai University of Traditional Chinese Medicine), F. C. Ma(Shanghai Cell Therapy Research Institute), Xinhong Guan(Shanghai University)
Cited by 0
Related Papers
Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion
|Nature Communications|2017|268
Regenerative proliferation of differentiated cells by mTORC1‐dependent paligenosis
|The EMBO Journal|2018|207
MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1
|Oncogene|2011|187
The 4-1BB Costimulation Augments the Proliferation of CD4+CD25+ Regulatory T Cells
|The Journal of Immunology|2004|163